TWO YEAR OUTCOMES OF "TREAT AND EXTEND" INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Retina
; 38(1): 20-28, 2018 Jan.
Article
in En
| MEDLINE
| ID: mdl-28145976
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Visual Acuity
/
Receptors, Vascular Endothelial Growth Factor
/
Wet Macular Degeneration
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
Retina
Year:
2018
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United States